These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34179832)

  • 1. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.
    Shin YH; Shin JI; Moon SY; Jin HY; Kim SY; Yang JM; Cho SH; Kim S; Lee M; Park Y; Kim MS; Won HH; Hong SH; Kronbichler A; Koyanagi A; Jacob L; Smith L; Lee KH; Suh DI; Lee SW; Yon DK
    Lancet Rheumatol; 2021 Oct; 3(10):e698-e706. PubMed ID: 34179832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
    Hanberg JS; Fu X; Wang X; Patel NJ; Kawano Y; Schiff A; Kowalski EN; Cook CE; Vanni KMM; Guzzo K; Qian G; Bade KJ; Saavedra A; Venkat R; Srivatsan S; Zhang Y; Sparks JA; Wallace ZS
    Lancet Rheumatol; 2024 Jan; 6(1):e21-e30. PubMed ID: 38258675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
    Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
    Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study.
    Qian G; Wang X; Patel NJ; Kawano Y; Fu X; Cook CE; Vanni KMM; Kowalski EN; Banasiak EP; Bade KJ; Srivatsan S; Williams ZK; Todd DJ; Weinblatt ME; Wallace ZS; Sparks JA
    Lancet Rheumatol; 2023 Mar; 5(3):e139-e150. PubMed ID: 36844970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
    Qian G; Wang X; Patel NJ; Kawano Y; Fu X; Cook CE; Vanni KMM; Kowalski EN; Banasiak EP; Bade KJ; Srivatsan S; Williams ZK; Todd DJ; Weinblatt ME; Wallace ZS; Sparks JA
    medRxiv; 2022 Oct; ():. PubMed ID: 36324801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.
    Yang JM; Koh HY; Moon SY; Yoo IK; Ha EK; You S; Kim SY; Yon DK; Lee SW
    J Allergy Clin Immunol; 2020 Oct; 146(4):790-798. PubMed ID: 32810517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study.
    Kim MS; Lee H; Lee SW; Kwon R; Rhee SY; Lee JA; Koyanagi A; Smith L; Fond G; Boyer L; Lee J; Rahmati M; Shin JY; Min C; Shin JI; Yon DK
    Ann Intern Med; 2024 Mar; 177(3):291-302. PubMed ID: 38437702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study.
    Lee SW; Kim SY; Moon SY; Yang JM; Ha EK; Jee HM; Shin JI; Cho SH; Yon DK; Suh DI
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2262-2271.e2. PubMed ID: 33931377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Use and COVID-19 Infectivity and Severity in South Korea: Two Population-Based Nationwide Cohort Studies.
    Lee SW; Kim SY; Moon SY; Yoo IK; Yoo EG; Eom GH; Kim JM; Shin JI; Jeong MH; Yang JM; Yon DK
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29379. PubMed ID: 34623311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case-Control Study from Astana, Kazakhstan.
    Rutskaya-Moroshan K; Abisheva S; Abisheva A; Amangeldiyeva Z; Vinnik T; Batyrkhan T
    Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336418
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands.
    Boekel L; Atiqi S; Leeuw M; Hooijberg F; Besten YR; Wartena R; Steenhuis M; Vogelzang E; Webers C; Boonen A; Gerritsen M; Lems WF; Tas SW; van Vollenhoven RF; Voskuyl AE; van der Horst-Bruinsma I; Nurmohamed M; Rispens T; Wolbink G
    Lancet Rheumatol; 2023 Jul; 5(7):e375-e385. PubMed ID: 37398978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Severe SARS-CoV-2 Infection in Patients with Autoimmune Rheumatic Diseases in Qatar: A Cohort Matched Study.
    Alsaed O; Alemadi S; Satti E; Becetti K; Saleh R; Ashour H; Hamed M; Alam F; Alrimawi Y; Nader J; Chaponda M; Awadh B; Hammoudeh M
    Qatar Med J; 2022; 2022(3):24. PubMed ID: 35813704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study.
    Svensson ALL; Emborg HD; Bartels LE; Ellingsen T; Adelsten T; Cordtz R; Dreyer L; Obel N
    Ann Rheum Dis; 2023 Oct; 82(10):1359-1367. PubMed ID: 37414519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.